David Gruber

Biography

David Gruber MD, MBA is a Managing Director and Director of Research with Alvarez & Marsal Healthcare Industry Group (HIG) in New York, specializing in strategy, business development, consumer engagement, innovation, new ventures, technology, analytics and health benefits. He is currently responsible for thought leadership and model development within HIG, co-leads A&M health benefit activities and is involved in a wide range of consulting projects. Dr. Gruber brings 30 years of diversified healthcare experience as a consultant, corporate executive, Wall Street analyst and physician. Before A&M, he spent three years as the Founder of Healthcare Convergence Associates, a consulting firm focused on the convergence of healthcare, technology and the consumer. Assignments included working with a multinational to explore tele-health opportunities; a medical device maker to assess the feasibility of a proposed asthma and COPD technology; a pharmacy benefit manager to define innovative approaches to medication adherence in diabetes; a national retailer exploring health and wellness; a Canadian company interested in preventing nosocomial infections; and a major Wireless Health Institute to develop its strategic plan. He was also involved in three healthcare-related IT start-ups. Until 2008, Dr. Gruber was VP of Corporate Development and New Ventures with the Johnson & Johnson Consumer Group of Companies, focusing on dermatology / aesthetics, consumer engagement and wireless health. In 1995-2004, he worked on Wall Street as a top-ten rated medical supplies and devices analyst at Lehman Brothers, Piper Jaffray and Sanford Bernstein. He was also the lead analyst for the initial public offering of Intuitive Surgical (robotics) and Given Imaging, and a merchant banking investment in Therasense. Before entering Wall Street, Dr. Gruber was VP of Planning and Business Development for the $1.6 billion healthcare group at Bristol-Myers that included Zimmer, ConvaTec, Linvatec and Xomed-Treace. There, he represented the company on the Health Industry Manufacturing Association (HIMA) as it deliberated the merits of the Hillary Clinton healthcare reform proposals. He recently appeared on NPR and C-Span; was quoted in the Washington Post, LA Times, The Deal, Healthcare Finance News, Managed Care Executive, Managed Care Outlook, Becker’s Hospital Review, Inside Health Policy; and published in the Journal of Diabetes Science & Technology, Turnaround Management Association Newsletter of Corporate Renewal and American Bankruptcy Institute Journal. Dr. Gruber is a magna cum laude graduate of a six-year BS-MD program, having received a bachelor’s degree from Sophie Davis School of Biomedical Education, CCNY in 1981 and a medical degree from the Mt. Sinai School of Medicine in 1983. He also has an MBA from Columbia University and was a Kellogg Foundation National Fellow. He is currently a Senior Fellow, Healthcare Innovation and Technology Lab (HITLAB) at Columbia Presbyterian and an elected Trustee to the Teaneck Board of Education.

Research Interest

David Gruber specializes in strategy, business development, consumer engagement, innovation, new ventures, technology, analytics and health benefits and he has 30 years of healthcare experience as a consultant, corporate executive, Wall Street analyst and physician